R. Louis (Liege, Belgium), R. Lutter (Amsterdam, The Netherlands)
Relationship between sputum level of matrix metallopreteinase (MMP-9)/tissue inhibitor of metalloproteinase (TIMP-1) and methacholine bronchial hyper-reactivity in asthma
I. M. El-Akkary, Z. A. El-Kholy, M. E. El-Seweify, M. A. Abdel Mohsen (Alexandria, Egypt)
|  |
Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma
P. J. Thompson, S. Aggarwal, N. L. Misso (Perth, Australia)
| |
Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma
J. Hara, M. Fujimura, S. Myou, N. Ohkura, S. Furusho (Kanazawa, Japan)
| |
Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD
M. Tsoumakidou, E. Papadopouli, N. Tzanakis, N. M. Siafakas (Heraklion, Greece)
| |
Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthma
L. Hemelaers, J. L. Corhay, M. Henket, J. Sele, R. Louis (Liege, Belgium)
| |
Evaluation of CD203c expression on induced sputum cells
P. Pignatti, D. Moretto, G. Calcagno, M. R. Yacoub, P. Pisati, G. Moscato (Pavia, Italy)
| |
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
I. Malkusova, V. Hrasko, J. Hanzlikova, P. Panzner (Plzen, Czech Republic)
| |
Exhaled breath condensate (EBC): changes in magnesium, pH and conductivity after exposure to swine house dust or inhaled LPS
F. Acevedo (Stockholm, Sweden)
| |
Eosinophil and neutrophilic chemotactic activity in the exhaled breath condensate of stable patients with asthma and COPD
J. L. Corhay, M. Henket, J. Sele, L. Hemmelaers, R. Louis (Liege, Belgium)
| |
Exhaled breath condensate (EBC) levels of eotaxin and macrophage-derived chemokine (MDC) in stable adult asthma patients
F. W. Ko, C. Y. Lau, T. F. Leung, G. W. Wong, M. C. Chan, D. S. Hui (Shatin, Hong Kong)
| |
Chemotactic activity of RANTES in nasal lavages obtained from patients with aspirin hypersensitivity
I. Kuprys-Lipinska, M. Kupczyk, B. Kuzminska, P. Gorski, P. Kuna (Lodz, Poland)
| |
Chemotactic activity of MCP-3 in nasal lavages obtained from patients with aspirin hypersensitivity
M. Kupczyk, I. Kuprys-Lipinska, B. Kuzminska, P. Gorski, P. Kuna (Lodz, Poland)
| |
IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients
L. I. Volkova, O. V. Astafurova, M. V. Fleming, N. N. Filonova, V. V. Klimov, N. V. Cherdyntseva, S. V. Smirnova (Tomsk, Krasnoyarsk, Russian Federation)
| |
Determinants of eNO levels in young adults
C. J. van Asch, W. A. F. Balemans, M. M. Rovers, A. G. M. Schilder, C. K. van der Ent (Utrecht, Netherlands)
| |
Increased small airway involvement in asthma compared to those with rhinitis and bronchial hyperresponsiveness, measured by fractional nitric oxide (NO) and impulse oscillometry (IOS)
D. Aronsson, L. Bjermer, E. Tufvesson (Lund, Sweden)
| |
Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control
V. E. Quaedvlieg, S. A. Kleis, J. F. Sele, M. B. Henket, R. E. Louis (Liege, Belgium)
| |
Total and allergen-specific IgE and nitric oxide (NO) flow-independent parameters
A. Malinovschi, C. Janson, T. Holmkvist, D. Norbäck, P. Meriläinen, M. Högman (Uppsala, Sweden)
| |
Long-term variation of exhaled nitric oxide
M. Andersson, K. Wass, B. Bake, A. C. Olin (Gothenburg, Sweden)
| |
Bronchial diffusing capacity of NO is increased in patients with allergic rhinitis
T. Mäkinen, L. Lehtimäki, H. Lehtonen, H. Kankaanranta, E. Moilanen (Tampere, Finland)
| |
Base nitric oxide level in saliva in patients with COPD
G. L. Ignatova, L. A. Stepanisheva, S. N. Teplova, J. N. Mikryukova, E. R. Zvenjatskaya (Chelyabinsk, Russian Federation)
| |